IP Library › Assignment 040059/0007
Patent Assignment
Reel/Frame 040059/0007

Patent Security Agreement

Recorded: 2016-09-16 Pages: 28
Assignor
Assignee
CITIBANK, N.A., AS COLLATERAL AGENT
390 GREENWICH ST., NEW YORK, NEW YORK, 10013
Covered Properties (37)
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 6,576,235 →
Application: 09/370,084 →
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
Patent: 6,783,965 →
Application: 09/501,730 →
Urate Oxidase
Patent: 7,056,713 →
Application: 09/762,097 →
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 7,723,089 →
Application: 09/839,946 →
Publication: US 2003/0166249
Conjugates prepared with aggregate-free proteins
Application: 10/928,370 →
Publication: US 2005/0014240
Urate oxidase
Application: 11/357,028 →
Publication: US 2006/0188971
Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of Peg-Uricase
Patent: 8,148,123 →
Application: 11/539,475 →
Publication: US 2007/0274977
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 7,927,589 →
Application: 11/833,590 →
Publication: US 2008/0031864
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
Patent: 7,927,852 →
Application: 11/882,750 →
Publication: US 2008/0057048
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
Application: 11/899,688 →
Publication: US 2008/0159976
Purification of Proteins With Cationic Surfactant
Patent: 9,534,013 →
Application: 11/918,292 →
Publication: US 2009/0317889
Variant Form of Urate Oxidase and Use Thereof
Patent: 7,811,800 →
Application: 11/918,296 →
Publication: US 2009/0209021
Variant Forms of Urate Oxidase and Use Thereof
Patent: 8,188,224 →
Application: 11/918,297 →
Publication: US 2009/0169534
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 8,067,553 →
Application: 12/769,570 →
Publication: US 2010/0323422
Peg-Urate Oxidase Conjugates and Use Thereof
Application: 12/769,572 →
Publication: US 2010/0323423
Variant Form of Urate Oxidase and Use Thereof
Patent: 7,964,381 →
Application: 12/879,084 →
Publication: US 2011/0104751
PEG-Urate Oxidase Conjugates and Use Thereof
Patent: 8,618,267 →
Application: 13/083,152 →
Publication: US 2013/0052677
Method for Purifying Urate Oxidase Tetramers and Octamers
Patent: 8,921,064 →
Application: 13/085,793 →
Publication: US 2011/0287466
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,034,594 →
Application: 13/107,498 →
Publication: US 2011/0217755
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,178,334 →
Application: 13/226,891 →
Publication: US 2012/0070876
PEG-Urate Oxidase Conjugates and Use Thereof
Application: 13/306,336 →
Publication: US 2012/0149083
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Patent: 9,377,454 →
Application: 13/379,704 →
Publication: US 2012/0301454
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,293,228 →
Application: 13/452,151 →
Publication: US 2012/0225046
Variant Forms of Urate Oxidase and Use Thereof
Patent: 8,541,205 →
Application: 13/461,170 →
Publication: US 2012/0309085
Variant Form of Urate Oxidase and Use Thereof
Patent: 8,465,735 →
Application: 13/623,512 →
Publication: US 2013/0084273
Variant Forms of Urate Oxidase and Use Thereof
Patent: 9,017,980 →
Application: 13/972,167 →
Publication: US 2013/0330803
Aggregate-Free Urate Oxidase For Preparation of Non-Immunogenic Polymer Conjugates
Application: 14/462,368 →
Publication: US 2014/0363414
Variant Forms of Urate Oxidase and Use Thereof
Patent: 9,670,467 →
Application: 14/671,246 →
Publication: US 2015/0197732
Peg-Urate Oxidase Conjugates and Use Thereof
Patent: 9,885,024 →
Application: 14/806,494 →
Publication: US 2016/0160188
Urate Oxidase
Application: 60/095,489 →
Peg-Urate Oxidase Conjugates and Use Thereof
Application: 60/219,318 →
Purification of proteins with cationic surfactant
Application: 60/670,520 →
Variant form of urate oxidase and use thereof
Application: 60/670,541 →
Variant forms of urate oxidase and use thereof
Application: 60/670,573 →
Routine Serum Uric Acid (SUA) Monitoring Predicts Antibody-Mediated Loss of Response and Infusion Reaction Risk During Pegloticase Therapy
Application: 61/248,698 →
Developments related to the treatment of gout
Application: 61/269,669 →
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegloticase Therapy
Application: 61/298,718 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 14, 2000
From: WILLIAMS, L. DAVID; SAIFER, MARK G. P.; SHERMAN, MERRY R.; HERSHFIELD, MICHAEL S.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.; DUKE UNIVERSITY
Reel/Frame 010706/0534 →
Assignment of Assignor's Interest May 22, 2000
From: SHERMAN, MERRY R., PH.D.; SAIFER, MARK G.P., PH.D.; WILLIAMS, DAVID, PH.D.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 010836/0572 →
Assignment of Assignor's Interest Feb 2, 2001
From: HERSHFIELD, MICHAEL; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 011545/0995 →
Assignment of Assignor's Interest Nov 28, 2001
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 012320/0572 →
Assignment of Assignor's Interest Nov 30, 2001
From: WILLIAMS, L. DAVID; SAIFER, MARK G. P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 012320/0564 →
Assignment of Assignor's Interest May 24, 2006
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 017663/0313 →
Assignment of Assignor's Interest Aug 28, 2007
From: REHRIG, CLAUDIA D.; HUANG, WILLIAM; HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 019756/0045 →
Assignment of Assignor's Interest Oct 24, 2007
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 020005/0757 →
Assignment of Assignor's Interest Oct 24, 2007
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 020003/0964 →
Assignment of Assignor's Interest Nov 19, 2007
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 020133/0479 →
Assignment of Assignor's Interest Nov 19, 2007
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 020133/0551 →
Assignment of Assignor's Interest Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020384/0974 →
Assignment of Assignor's Interest Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020386/0145 →
Assignment of Assignor's Interest Jan 18, 2008
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020383/0946 →
Assignment of Assignor's Interest Mar 14, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA; REHRIG, CLAUDIA D.; HUANG, WILLIAM
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020651/0468 →
Confirmatory License Jul 1, 2008
From: DUKE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021176/0511 →
Assignment of Assignor's Interest Jul 23, 2008
From: HERSHFIELD, MICHAEL S.
To: DUKE UNIVERSITY
Reel/Frame 021278/0683 →
Assignment of Assignor's Interest Jul 31, 2009
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 023037/0222 →
Assignment of Assignor's Interest Aug 5, 2009
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 023053/0802 →
Assignment of Assignor's Interest Aug 22, 2011
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 026784/0154 →
Assignment of Assignor's Interest Aug 22, 2011
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 026783/0095 →
Assignment of Assignor's Interest Oct 5, 2011
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 027020/0822 →
Assignment of Assignor's Interest Oct 5, 2011
From: WILLIAMS, L. DAVID; SAIFER, MARK G.P.; SHERMAN, MERRY R.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 027020/0843 →
Security Agreement Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Assignment of Assignor's Interest Jun 27, 2013
From: SHERMAN, MERRY R.; SAIFER, MARK G.P.; WILLIAMS, L. DAVID
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 030697/0968 →